A $4 Billion Error, and Cold Facts About Investing in China

One of China’s biggest drugmakers said it overstated its assets by $4.4 billion, calling into question the quality and standard of accounting at Chinese listed companies.
A $4 Billion Error, and Cold Facts About Investing in China
An investor monitors stock prices at a securities company in Hangzhou, Zhejiang Province on Dec. 3, 2018. STR/AFP/Getty Images
Fan Yu
Updated:
News Analysis

One of China’s biggest drugmakers recently said that it overstated its assets by $4.4 billion, calling into question the quality and standard of accounting at Chinese listed companies.

Fan Yu
Fan Yu
Author
Fan Yu is an expert in finance and economics and has contributed analyses on China's economy since 2015.
Related Topics